Cotrimoxazole safety study
- Principal Investigator(s): Scott Dryden-Peterson
- Study Contact: Scott Dryden-Peterson, +2.677.447.2522, scott_peterson@post.harvard.edu
- Description of Subjects: Infants born to HIV-infected women
- Location (Domestic vs. International): Botswana
- Enrollment Period: 2008-2009
- Enrollment Goal: 444 mother-infant pairs
- Key Exclusion and Inclusion Criteria: Inclusion: live born infants from HIV-infected mothers in Botswana
- Available Biological Specimens:
- How to Request Access: Email PI
- Available Data Description: longitudinal outcome data, maternal health history
- Optional Additional Comments: biologic specimens only available for infants born to HIV-infected mothers. No maternal specimens available. Few infants HIV-infected.
See also:
Blood, serum, and plasma, HIV+ and HIV-, Botswana Harvard AIDS Institute Partnership (BHP), Brigham and Women's Hospital, Studies > 1000 Participants, Studies Started Post-2005, International, Scott Dryden-Peterson, ART